Human Health Risk Assessment for Pharmaceuticals in the Environment: Existing Practice, Uncertainty, and Future Directions

  • Williams E
  • Brooks B
N/ACitations
Citations of this article
31Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Fish on Prozac. Drugs found in drinking water. India’s drug problem. Chances are you’ve seen these headlines. Human pharmaceuticals represent environmental contaminants of emerging concern, and receive unprecedented attention from the scientific, regulatory and public sectors. This timely contribution, prepared by international experts in the field, synthesizes and critically examines topics ranging from regulations, environmental chemistry and exposure analysis, to comparative pharmacology, environmental toxicology, water treatment technologies and pharmaceutical take back programs. Compared to historical contaminants, chemical and biological attributes of human pharmaceuticals present unique challenges to environmental management, but lessons learned from the study of pharmaceuticals promise to advance prospective and retrospective approaches to assess the impacts of industrial chemicals. Students and environmental scientists, managers, regulators, and public health professionals will benefit from this forward-thinking treatment of human pharmaceuticals in the environment.

Cite

CITATION STYLE

APA

Williams, E. S., & Brooks, B. W. (2012). Human Health Risk Assessment for Pharmaceuticals in the Environment: Existing Practice, Uncertainty, and Future Directions (pp. 167–224). https://doi.org/10.1007/978-1-4614-3473-3_8

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free